| Sofosbuvir | ||
| Sovaldi, Gilead Sciences | ||
| 28 cpr riv 400 mg |
€ 27133,33 |
C-RNRL |
| Sofosbuvir + Ledipasvir | ||
| Harvoni, Gilead Sciences | ||
| 28 cpr riv 400 mg/90 mg |
€ 29846,67 |
C-RNRL |
| Sofosbuvir + Velpatasvir | ||
| Epclusa, Gilead Sciences | ||
| 28 cpr riv 200 mg/50 mg | € 24824,77 | A-RNRL |
| 28 cpr riv 400 mg/100 mg | € 24824,77 | A-RNRL |
| 28 bust 150 mg/37,5 mg | € 24824,77 | A-RNRL |
| 28 bust 200 mg/50 mg |
€ 24824,77 |
A-RNRL |
| Sofosbuvir + Velpatasvir + Voxilaprevir | ||
| Vosevi, Gilead Sciences | ||
| 28 cpr 400 mg/100 mg/100 mg | € 26982,04 | A-RNRL |